Lactate Dehydrogenase Levels as A Marker of COVID-19 Severity
DOI:
https://doi.org/10.24293/ijcpml.v29i1.1910Keywords:
COVID-19, lactate dehydrogenase, markerAbstract
Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Knowing the severity of COVID-19 is important during a pandemic. Measurement of Lactate Dehydrogenase (LDH) levels is a simple, quick, and widely available laboratory test in most health facilities. Lactate dehydrogenase levels change significantly in patients with tissue damage including COVID-19 disease. The purpose of this study was to analyze the LDH levels as a marker of the severity of COVID-19. The research method used was a cross-sectional approach using primary data from 70 suspected COVID-19 patients from June to July 2021 at Labuang Baji Hospital, Hasanuddin University Hospital, and Makassar City Hospital. Samples were grouped into mild, moderate, and severe COVID-19. The LDH levels at the time of hospital admission were measured using an Architect device. Chi-Square, Kruskal-Wallis, and ROC curve statistical tests were used to obtain the LDH value with a significant value of p<0.05. The sample consisted of 24 mild COVID-19, 23 moderate COVID-19, and 23 severe COVID-19. The LDH levels in mild COVID-19 were 101.00 U/L (74.00-156.00 U/L) significantly different from moderate COVID-19 was 143.00 U/L (126.00-253.00 U/L) and COVID-19 were 291.00 U/L (177.00-655.00 U/L) (p<0.001) and had a very strong positive correlation (r=0.914). The ROC curve showed that LDH had a sensitivity of 91.3%, specificity of 94.7% with the cut-off >250.5 U/L, NPV of 96.4%, PPV of 87.5%, and accuracy of 91.3%. LDH levels increase along with the increasing severity of COVID-19 caused by tissue damage due to increased inflammatory response. LDH can be used as a marker of COVID-19 severity.Downloads
References
Kementerian Kesehatan RI. Pedoman pencegahan dan pengendalian Coronavirus diseases (COVID-19). Kementrian Kesehatan RI, 2020; 5: 178.
Perhimpunan Dokter Paru Indonesia. Pneumonia COVID-19. Diagnosis dan penatalaksanaannya di
Indonesia. 2020; 8.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, et al. Coronavirus disease 2019: Tinjauan
literatur terkini. J. Penyakit Dalam Indonesia, 2020; 7: 45-67.
Han Y, Yang H. The transmission and diagnosis of 2019 novel Coronavirus infection disease (COVID?19): A Chinese perspective. J Med Virol, 2020; 92: 639-644.
Dong X, Sun L, Li Y. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and
critically ill patients with COVID-19. Int J Med Sci, 2020; 17: 2225-2231.
Shi J, Li Y, Zhou X, Zhang Q, Ye X, et al. Lactate dehydrogenase and susceptibility to deterioration
of mild COVID-19 patients: A multicenter nested case-control study. BMC Med, 2020; 18: 4-9.
Szarpak L, Ruetzler K, Safiejko K, Hampel M, Pruc M, et al. Lactate dehydrogenase level as a COVID-19
severity marker. Am J Emerg Med, 2020; 4: 11-12.
Zhou Y, Ding N, Yang G, Peng W, Tang F, et al. Serum lactate dehydrogenase level may predict acute
respiratory distress syndrome of patients with fever infected by SARS-CoV-2. Ann, Transl Med, 2020; 8:
-1118.
Henry BM, Aggarwal G, Wong J, Benoit S, Vikse J, et al. Lactate dehydrogenase levels predict Coronavirus Disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med, 2020; 38: 1722-1726.
Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet, 2020; 395: 497-506.
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol, 2020; 108427.
Wei Y, Zeng W, Huang X, Li J, Qiu X, et al. Clinical characteristics of 276 hospitalized patients with
Coronavirus disease 2019 in Zengdu District, Hubei Province: A single-center descriptive study. BMC Infect Dis, 2020; 20: 1-10.
Badan Pusat Statistik. Sensus penduduk tahun 2020. Sensus penduduk tahun 2020. BPS, 2021; 15.
Li S, Jiang L, Li X, Lin F, Wang Y, et al. Clinical and pathological investigation of patients with severe
COVID-19. JCI Insight, 2020; 5.
Kangdra WY. Karakteristik klinis dan faktor komorbid pada Pasien dalam Pengawasan (PDP) Coronavirus Disease 2019 (COVID-19) di RS Mitra Medika Amplas. Repositori Institusi USU, 2021; 1523: 1.
Li G, Fan Y, Lai Y, Han T, Li Z, et al. Coronavirus infections and immune responses. J Med Virol, 2020;
: 424-432.
Zhang B, Zhou X, Zhu C, Song Y, Feng F, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci, 2020; 7: 157.
Guo L, Ren L, Yang S, Xiao M, Chang D, et al. Profiling early humoral response to diagnose novel
Coronavirus Disease (COVID-19). Clin Infect Dis, 2020; 71: 778-785.
Qin C, Zhou L, Hu Z, Zhang S, Yang S, et al. Dysregulation of immune response in patients with
Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis, 2020; 71: 762-768.
Thevarajan I, Nguyen TH, Koutsakos M, Druce J, Caly L, et al. Breadth of concomitant immune responses prior to patient recovery: A case report of non-severe COVID-19. Nat Med, 2020; 26: 453-455.
Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: Host-directed therapies should be an option. Lancet, 2020; 395: e35-e36.
Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, et al. Coronavirus Diseases (COVID-19)
current status and future perspectives: A narrative review. Int J Environ Res Public Health, 2020; 17: 2690.
Henry BM, Aggarwal G, Wong J, Benoit S, Vikse J, et al.Lactate dehydrogenase levels predict Coronavirus Disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med, 2020; 38: 1722-1726.
Tjahyadi RM, Astuti T, Listyoko AS. COVID-19: Correlation between CRP and LDH to disease severity
and mortality in hospitalized COVID-19 patients. Medica Hosp J Clin Med, 2020; 7: 144-149.
Hu J, Zhou J, Dong F, Tan J, Wang S, et al. Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19. Medicine (Baltimore), 2020; 99.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
